Campbell K, Kao PC, Naranjo A, Kamijo T, Ramanujachar R, London WB, et al. Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2023 Feb;70(2):e30054. PubMed PMID: 36316811. PMCID: PMC9988328. Epub 20221031. eng.

May 5, 2026

Study ID Citation

Campbell K, Kao PC, Naranjo A, Kamijo T, Ramanujachar R, London WB, DuBois SG. Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2023 Feb;70(2):e30054. doi: 10.1002/pbc.30054. Epub 2022 Oct 31. PubMed PMID: 36316811; PubMed Central PMCID: PMC9988328.